Search
Danaher Corp
DHRAdd to Watchlist
179.265USD
+1.075+0.60%
Market hours （ET）Quotes delayed by 15 min
126.87BMarket Cap
34.52P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.60%
5 Days
-1.01%
1 Month
+4.22%
6 Months
-21.38%
Year to Date
-21.69%
1 Year
-8.72%
Key Figures
180.570Open
181.490High
1.90MVolume
34.52P/E TTM
19.44P/E Dynamic
1.360Dividend TTM
0.27%Turnover Ratio
178.190Prev. Close
177.070Low
221.51MTurnover
32.54P/E Static
2.40P/B
0.76%Div Yield TTM
4.52%ROA
242.80052wk High
0.50Volume Ratio
3.90BNet Profit
707.70MShares
5.1926EPS TTM
0.81Beta
7.08%ROE
160.93052wk Low
2.48%Amplitude
60.34%Gross Margin
126.87BMarket Cap
1.84Reward/Risk
1.53%Risk Rate
TradingKey Stock Score of Danaher Corp
Currency: USD Updated: 2026-06-22Key Insights
Danaher Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 29 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 240.06.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Danaher Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
38°C
Very Low
Very High
Negative
Danaher Corp Highlights
StrengthsRisks
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 20.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.13%.
Undervalued
The company’s latest PE is 34.32, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 594.48M shares, decreasing 0.66% quarter-over-quarter.
Held by Al Gore
Star Investor Al Gore holds 7.97M shares of this stock.
Analyst Rating
Based on
28
analysts
Buy
Current Rating
240.064
Target Price
+35.50%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Danaher Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Danaher Corp Info
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Ticker SymbolDHR
CompanyDanaher Corp
CEOBlair (Rainer M)
Websitehttps://www.danaher.com/
Related Instruments
+0.29%
+0.73%
+2.84%
-0.11%
+0.17%
+1.60%
+1.63%
+3.03%
+0.28%
+0.44%
+2.19%
+3.14%
+0.73%
+0.36%
-0.78%
+2.99%
+0.46%
+2.37%
+1.18%Popular Instruments
73.335
-0.654 (-0.88%)
296.250
-0.760 (-0.26%)
201.240
-7.410 (-3.55%)
4122.010
-68.240 (-1.63%)
671.450
-61.170 (-8.35%)
1975.250
-298.480 (-13.13%)
1051.060
-160.320 (-13.23%)
346.920
-2.760 (-0.79%)
62326.240
-2077.560 (-3.23%)
381.670
-23.380 (-5.77%)
FAQs
What is the current price of Danaher Corp (DHR)?
The current price of Danaher Corp (DHR) is 178.29.
What is the symbol of Danaher Corp?
The ticker symbol of Danaher Corp is DHR.
What is the 52-week high of Danaher Corp?
The 52-week high of Danaher Corp is 242.80.
What is the 52-week low of Danaher Corp?
The 52-week low of Danaher Corp is 160.93.
What is the market capitalization of Danaher Corp?
The market capitalization of Danaher Corp is 126.12B.
Is Danaher Corp (DHR) currently rated as Buy, Hold, or Sell?
According to analysts, Danaher Corp (DHR) has an overall rating of Buy, with a price target of 240.06.
What is the Earnings Per Share (EPS TTM) of Danaher Corp (DHR)?
The Earnings Per Share (EPS TTM) of Danaher Corp (DHR) is 5.07.
